In contrast, the AWARD-11 trial for Trulicity showed modest weight loss as a secondary endpoint in type 2 diabetes patients: approximately 6.6 lbs with the 1.5mg dose, 8.4 lbs with 3mg, and 10.1 lbs (about 4.6 kg) with the highest 4.5mg dose at 36 weeks
Pay flexibly with Klarna Choose buy now, pay later to spread the cost over time.* 3
H., De Meester, I., Baerts, L., Vliegen, G., Inci, I., Yoshino, I., Weder, W., & Jungraithmayr, W
The active ingredient is identical to brand-name semaglutide, and every batch undergoes potency testing
I was a physical specimen
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study